Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.76 - $2.83 $3.62 Million - $5.82 Million
2,056,845 Added 39.56%
7,255,865 $18.4 Million
Q2 2023

Aug 14, 2023

SELL
$2.1 - $3.36 $1.31 Million - $2.09 Million
-621,917 Reduced 10.68%
5,199,020 $12 Million
Q1 2023

May 15, 2023

BUY
$2.13 - $3.6 $481,360 - $813,567
225,991 Added 4.04%
5,820,937 $14.8 Million
Q4 2022

Feb 14, 2023

BUY
$2.05 - $3.47 $1.44 Million - $2.44 Million
704,537 Added 14.41%
5,594,946 $14 Million
Q3 2022

Nov 14, 2022

BUY
$0.63 - $5.47 $966,906 - $8.4 Million
1,534,772 Added 45.74%
4,890,409 $14.2 Million

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.